MYX mayne pharma group limited
Add to My Watchlist 0.59% ! $5.10

Wow the US team were getting slammed! A shameful surprise that...

  1. Lodan
    154 Posts.
    lightbulb Created with Sketch. 26
    clock Created with Sketch.
    22/02/21
    23:36
    Post #: 51230591
    Wow the US team were getting slammed! A shameful surprise that people should feel that way; given the immense focus Mayne Pharma has placed on US expansion I would have thought they would have invested more in their US team


    MYX Price at posting: 31.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Red Mountain to map, sample Quartz Reef after landing big alluvial nugget haul
right-arrow Created with Sketch.
NEWS Profits after tax down -88%, and shares rocket – what's going on with Collins?
right-arrow Created with Sketch.
NEWS High-Grade Scandium Assays Returned at Syerston from Drilling Campaign
right-arrow Created with Sketch.
NEWS How Do You Trade? Take Our 1-Minute Survey & Share Your Style
right-arrow Created with Sketch.
NUZ Liquid Formulation of NUZ-001 Developed to Improve Patient Access and Experience
right-arrow Created with Sketch.
NEWS Uranium ignites: Is this the start of a supercycle?
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.10 		Change
0.030(0.59%) 		Mkt cap ! $414.3M
Open High Low Value Volume
$5.13 $5.14 $5.10 $180.6K 35.35K

Buyers (Bids)

No. Vol. Price($)
1 385 $5.10
 

Sellers (Offers)

Price($) Vol. No.
$5.11 142 7
View Market Depth
Last trade - 12.11pm 27/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.